Ads
related to: pde4 inhibitor copd examples in children video- Adverse Reactions
Learn About The Adverse Reactions
Of This Daily COPD Treatment.
- Samples & Savings
Request Samples For Your Practice
Daily Triple Therapy COPD Option.
- Dosing Information
HCPs: See The Dosing Information Of
This Once-Daily COPD Inhaler.
- Formulary Coverage
See If Your Patients Are Covered
With This Daily COPD Treatment.
- Triple Therapy Delivery
View The Delivery Methods Of This
Daily Triple Therapy COPD Option.
- Important Safety Info
Read About Safety & Side Effects
For A COPD Triple Therapy.
- Adverse Reactions
Search results
Results From The WOW.Com Content Network
A phosphodiesterase-4 inhibitor, commonly referred to as a PDE4 inhibitor, is a drug used to block the degradative action of phosphodiesterase 4 (PDE4) on cyclic adenosine monophosphate (cAMP). It is a member of the larger family of PDE inhibitors. The PDE4 family of enzymes are the most prevalent PDE in immune cells. They are predominantly ...
Piclamilast (RP 73401), is a selective PDE4 inhibitor. [1] It is comparable to other PDE4 inhibitors for its anti-inflammatory effects. It has been investigated for its applications to the treatment of conditions such as chronic obstructive pulmonary disease, bronchopulmonary dysplasia and asthma.
Roflumilast, sold under the brand name Daxas among others, is a medication used for the treatment of chronic obstructive pulmonary disease, [4] plaque psoriasis, [5] seborrheic dermatitis, [6] and atopic dermatitis. [5] It acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). [10] It has anti-inflammatory effects ...
It inhibits PDE4 to the greatest extent, but also shows significant inhibition of other PDE subtypes, and so acts as a selective PDE4 inhibitor or a non-selective phosphodiesterase inhibitor, depending on the dose. Piclamilast, a more potent inhibitor than rolipram. [25] Luteolin, supplement extracted from peanuts that also possesses IGF-1 ...
It showed reasonable efficacy for treating COPD, but side effects were problematic and it is unclear whether cilomilast will be marketed, or merely used in the development of newer drugs. [ 3 ] [ 4 ] Cilomilast is a second-generation PDE4 inhibitor with anti-inflammatory effects that target bronchoconstriction , mucus hypersecretion, and airway ...
Rolipram continues to be used in research as a well-characterized PDE4 inhibitor. [ 3 ] : 669 It has been used in studies to understand whether PDE4 inhibition could be useful in autoimmune diseases , [ 5 ] Alzheimer's disease, [ 6 ] cognitive enhancement, [ 7 ] spinal cord injury, [ 8 ] and respiratory diseases like asthma and COPD .
Adibendan; Aminophylline; Aminophylline dihydrate; Amipizone; Apremilast; Arofylline; Atizoram; Befuraline; Bemarinone hydrochloride; Bemoradan; Benafentrine; Bucladesine
The potential for selective phosphodiesterase inhibitors to be used as therapeutic agents was predicted in the 1970s by Weiss and coworkers. [5] This prediction has now come to pass in a variety of fields (e.g. sildenafil as a PDE5 inhibitor and Rolipram as a PDE4 inhibitor).
Ad
related to: pde4 inhibitor copd examples in children video